Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP145810.RAScj_TdmkrcAy1tm_9eElcVX5Pnz9Y-EnxAMNArDJ6mc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP145810.RAScj_TdmkrcAy1tm_9eElcVX5Pnz9Y-EnxAMNArDJ6mc130_assertion type Assertion NP145810.RAScj_TdmkrcAy1tm_9eElcVX5Pnz9Y-EnxAMNArDJ6mc130_head.
- NP145810.RAScj_TdmkrcAy1tm_9eElcVX5Pnz9Y-EnxAMNArDJ6mc130_assertion description "[Aberrant Nrf2 activation provoked by Keap1 alteration is one of the molecular mechanisms for chemotherapeutic resistance in gallbladder cancer ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP145810.RAScj_TdmkrcAy1tm_9eElcVX5Pnz9Y-EnxAMNArDJ6mc130_provenance.
- NP145810.RAScj_TdmkrcAy1tm_9eElcVX5Pnz9Y-EnxAMNArDJ6mc130_assertion evidence source_evidence_literature NP145810.RAScj_TdmkrcAy1tm_9eElcVX5Pnz9Y-EnxAMNArDJ6mc130_provenance.
- NP145810.RAScj_TdmkrcAy1tm_9eElcVX5Pnz9Y-EnxAMNArDJ6mc130_assertion SIO_000772 18692501 NP145810.RAScj_TdmkrcAy1tm_9eElcVX5Pnz9Y-EnxAMNArDJ6mc130_provenance.
- NP145810.RAScj_TdmkrcAy1tm_9eElcVX5Pnz9Y-EnxAMNArDJ6mc130_assertion wasDerivedFrom lhgdn-20090331 NP145810.RAScj_TdmkrcAy1tm_9eElcVX5Pnz9Y-EnxAMNArDJ6mc130_provenance.
- NP145810.RAScj_TdmkrcAy1tm_9eElcVX5Pnz9Y-EnxAMNArDJ6mc130_assertion wasGeneratedBy ECO_0000203 NP145810.RAScj_TdmkrcAy1tm_9eElcVX5Pnz9Y-EnxAMNArDJ6mc130_provenance.